Filamin A interacting protein 1-like as a therapeutic target in cancer

Bibliography

• Bravo-Cordero JJ, Hodgson L, Condeelis J. Directed cell invasion and migration during metastasis. Curr Opin Cell Biol 2012;24:277-83
   Google Scholar
• Kwon M, Hanna E, Lorang D, et al. Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy. Cancer Res 2008;68:7332-41
   PubMed Web of Science ®Google Scholar
• Burton ER, Gaffar A, Lee SJ, et al. Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer. Mol Cancer Res 2011;9:1126-38
   Google Scholar
• Kwon M, Lee SJ, Reddy S, et al. Down-regulation of filamin ainteracting protein 1-like is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers. PLoS One 2013;8:e82620
   Google Scholar
• Desotelle J, Truong M, Ewald J, et al. CpG Island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer. J Urol 2013;189:329-35
   PubMed Web of Science ®Google Scholar
• Xie C, Gou ML, Yi T, et al. Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels. Hum Gene Ther 2011;22:1413-22
   PubMed Web of Science ®Google Scholar
• Kwon M, Lee SJ, Wang Y, et al. Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis. Int J Cancer 2014;135:48-60
   Google Scholar
• Badano JL, Teslovich TM, Katsanis N. The centrosome in human genetic disease. Nat Rev Genet 2005;6:194-205
   Google Scholar
• Bahmanyar S, Kaplan DD, Deluca JG, et al. beta-Catenin is a Nek2 substrate involved in centrosome separation. Genes Dev 2008;22:91-105
   PubMed Web of Science ®Google Scholar
• Gerdes JM, Liu Y, Zaghloul NA, et al. Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response. Nat Genet 2007;39:1350-60
   PubMed Web of Science ®Google Scholar
• Wigley WC, Fabunmi RP, Lee MG, et al. Dynamic association of proteasomal machinery with the centrosome. J Cell Biol 1999;145:481-90
   PubMed Web of Science ®Google Scholar
• Freed E, Lacey KR, Huie P, et al. Components of an SCF ubiquitin ligase localize to the centrosome and regulate the centrosome duplication cycle. Genes Dev 1999;13:2242-57
   PubMed Web of Science ®Google Scholar
• Fumoto K, Kadono M, Izumi N, et al. Axin localizes to the centrosome and is involved in microtubule nucleation. EMBO Rep 2009;10:606-13
   PubMed Web of Science ®Google Scholar
• Kaplan DD, Meigs TE, Kelly P, et al. Identification of a role for beta-catenin in the establishment of a bipolar mitotic spindle. J Biol Chem 2004;279:10829-32
   PubMed Web of Science ®Google Scholar
• Kim SM, Choi EJ, Song KJ, et al. Axin localizes to mitotic spindles and centrosomes in mitotic cells. Exp Cell Res 2009;315:943-54
   PubMed Web of Science ®Google Scholar
• Louie RK, Bahmanyar S, Siemers KA, et al. Adenomatous polyposis coli and EB1 localize in close proximity of the mother centriole and EB1 is a functional component of centrosomes. J Cell Sci 2004;117:1117-28
   PubMed Web of Science ®Google Scholar
• Park TJ, Mitchell BJ, Abitua PB, et al. Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells. Nat Genet 2008;40:871-9
   PubMed Web of Science ®Google Scholar
• Sillibourne JE, Milne DM, Takahashi M, et al. Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450. J Mol Biol 2002;322:785-97
   PubMed Web of Science ®Google Scholar
• Wakefield JG, Stephens DJ, Tavare JM. A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J Cell Sci 2003;116:637-46
   PubMed Web of Science ®Google Scholar
• Huang P, Senga T, Hamaguchi M. A novel role of phospho-beta-catenin in microtubule regrowth at centrosome. Oncogene 2007;26:4357-71
   PubMedGoogle Scholar
• Hadjihannas MV, Bruckner M, Behrens J. Conductin/axin2 and Wnt signalling regulates centrosome cohesion. EMBO Rep 2010;11:317-24
   PubMed Web of Science ®Google Scholar
• Fuentealba LC, Eivers E, Geissert D, et al. Asymmetric mitosis: unequal segregation of proteins destined for degradation. Proc Natl Acad Sci USA 2008;105:7732-7
   PubMedGoogle Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90
   PubMed Web of Science ®Google Scholar
• Weinberg RA. Mechanisms of malignant progression. Carcinogenesis 2008;29:1092-5
   PubMedGoogle Scholar
• Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-73
   PubMed Web of Science ®Google Scholar
• Kwon M. Epithelial-to-mesenchymal transition and cancer stem cells: emerging targets for novel cancer therapy. Cancer Gene Ther 2014;21:179-80
   Google Scholar
• Mok SC, Wong KK, Chan RK, et al. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol 1994;52:247-52
   PubMed Web of Science ®Google Scholar
• Matei D, Graeber TG, Baldwin RL, et al. Gene expression in epithelial ovarian carcinoma. Oncogene 2002;21:6289-98
   PubMed Web of Science ®Google Scholar
• Quaye L, Dafou D, Ramus SJ, et al. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. Hum Mol Genet 2009;18:1869-78
   Google Scholar
• Notaridou M, Quaye L, Dafou D, et al. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer 2011;128:2063-74
   PubMed Web of Science ®Google Scholar
• Schwarze SR, DePrimo SE, Grabert LM, et al. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J Biol Chem 2002;277:14877-83
   PubMed Web of Science ®Google Scholar
• Schwarze SR, Fu VX, Desotelle JA, et al. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia 2005;7:816-23
   PubMed Web of Science ®Google Scholar
• Klener P, Szynal M, Cleuter Y, et al. Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells. J Virol 2006;80:1922-38
   Google Scholar
• Poole LJ, Yu Y, Kim PS, et al. Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi’s sarcoma-associated herpesvirus. J Virol 2002;76:3395-420
   PubMed Web of Science ®Google Scholar
• Mazzanti CM, Tandle A, Lorang D, et al. Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells. Genome Res 2004;14:1585-93
   PubMed Web of Science ®Google Scholar
• Tandle AT, Mazzanti C, Alexander HR, et al. Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells. Cytokine 2005;30:347-58
   Google Scholar
• Barton CA, Hacker NF, Clark SJ, et al. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecol Oncol 2008;109:129-39
   Google Scholar
• Matei DE, Nephew KP. Epigenetic therapies for chemoresensitization of epithelial ovarian cancer. Gynecol Oncol 2010;116:195-201
   PubMedGoogle Scholar
• Bojang P Jr, Ramos KS. The promise and failures of epigenetic therapies for cancer treatment. Cancer Treat Rev 2014;40:153-69
   PubMed Web of Science ®Google Scholar
• Hu Y, Mivechi NF. Promotion of heat shock factor Hsf1 degradation via adaptor protein filamin A-interacting protein 1-like (FILIP-1L). J Biol Chem 2011;286:31397-408
   Google Scholar
• Hajitou A, Trepel M, Lilley CE, et al. A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 2006;125:385-98
   PubMed Web of Science ®Google Scholar
• Lu H, Hallstrom TC. Sensitivity to TOP2 targeting chemotherapeutics is regulated by Oct1 and FILIP1L. PLoS One 2012;7:e42921
   Google Scholar
• Even-Ram S, Yamada KM. Cell migration in 3D matrix. Curr Opin Cell Biol 2005;17:524-32
   PubMed Web of Science ®Google Scholar
• Caswell PT, Spence HJ, Parsons M, et al. Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev Cell 2007;13:496-510
   PubMed Web of Science ®Google Scholar
• Song Y, Yang QX, Zhang F, et al. Suppression of nasopharyngeal carcinoma cell by targeting beta-catenin signaling pathway. Cancer Epidemiol 2012;36:e116-21
   Google Scholar
• Denys H, De Wever O, Nusgens B, et al. Invasion and MMP expression profile in desmoid tumours. Br J Cancer 2004;90:1443-9
   Google Scholar
• Valenta T, Hausmann G, Basler K. The many faces and functions of beta-catenin. EMBO J 2012;31:2714-36
   PubMed Web of Science ®Google Scholar
• Liu C, Li Y, Semenov M, et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002;108:837-47
   PubMed Web of Science ®Google Scholar
• Xing Y, Clements WK, Kimelman D, et al. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex. Genes Dev 2003;17:2753-64
   PubMed Web of Science ®Google Scholar
• Amin N, Vincan E. The Wnt signaling pathways and cell adhesion. Front Biosci 2012;17:784-804
   Google Scholar
• Kurayoshi M, Oue N, Yamamoto H, et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006;66:10439-48
   PubMed Web of Science ®Google Scholar
• Kurayoshi M, Yamamoto H, Izumi S, et al. Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling. Biochem J 2007;402:515-23
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Kitadai Y, Oue N, et al. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells. Gastroenterology 2009;137:242-52. 52 e1-6
   Google Scholar
• Matsumoto S, Fumoto K, Okamoto T, et al. Binding of APC and dishevelled mediates Wnt5a-regulated focal adhesion dynamics in migrating cells. EMBO J 2010;29:1192-204
   Google Scholar
• Badiglian Filho L, Oshima CT, De Oliveira Lima F, et al. Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer. Oncol Rep 2009;21:313-20
   Google Scholar
• Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003;5:367-77
   PubMed Web of Science ®Google Scholar
• Kikuchi A, Yamamoto H. Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci 2008;99:202-8
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Oue N, Sato A, et al. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 2010;29:2036-46
   PubMed Web of Science ®Google Scholar
• Weeraratna AT, Jiang Y, Hostetter G, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002;1:279-88
   PubMed Web of Science ®Google Scholar
• Huang CL, Liu D, Nakano J, et al. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor–an expression in non-small-cell lung cancer. J Clin Oncol 2005;23:8765-73
   PubMed Web of Science ®Google Scholar
• Pukrop T, Klemm F, Hagemann T, et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci USA 2006;103:5454-9
   PubMed Web of Science ®Google Scholar
• Hanaki H, Yamamoto H, Sakane H, et al. An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis. Mol Cancer Ther 2012;11:298-307
   Google Scholar
• Barbolina MV, Burkhalter RJ, Stack MS. Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment. Biochem J 2011;437:1-12
   Google Scholar
• Dwyer MA, Joseph JD, Wade HE, et al. WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res 2010;70:9298-308
   Google Scholar
• Uysal-Onganer P, Kawano Y, Caro M, et al. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol Cancer 2010;9:55
   PubMed Web of Science ®Google Scholar
• Mochmann LH, Bock J, Ortiz-Tanchez J, et al. Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG. Oncogene 2011;30:2044-56
   PubMed Web of Science ®Google Scholar
• Kirikoshi H, Sekihara H, Katoh M. Molecular cloning and characterization of human WNT11. Int J Mol Med 2001;8:651-6
   Google Scholar
• Zhu H, Mazor M, Kawano Y, et al. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor. Cancer Res 2004;64:7918-26
   Google Scholar
• Railo A, Pajunen A, Itaranta P, et al. Genomic response to Wnt signalling is highly context-dependent–evidence from DNA microarray and chromatin immunoprecipitation screens of Wnt/TCF targets. Exp Cell Res 2009;315:2690-704
   PubMedGoogle Scholar
• Ueno S, Weidinger G, Osugi T, et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA 2007;104:9685-90
   PubMed Web of Science ®Google Scholar
• Arend RC, Londono-Joshi AI, Straughn JM Jr, et al. The Wnt/beta-catenin pathway in ovarian cancer: a review. Gynecol Oncol 2013;131:772-9
   PubMed Web of Science ®Google Scholar
• Yoshida S, Furukawa N, Haruta S, et al. Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review. Int J Gynecol Cancer 2009;19:992-7
   Google Scholar
• Su HY, Lai HC, Lin YW, et al. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int J Cancer 2010;127:555-67
   PubMed Web of Science ®Google Scholar
• Zhai Y, Iura A, Yeasmin S, et al. MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma. Oncogene 2011;30:4152-62
   PubMedGoogle Scholar
• Ford CE, Jary E, Ma SS, et al. The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells. PLoS One 2013;8:e54362
   PubMed Web of Science ®Google Scholar
• Condello S, Cao L, Matei D. Tissue transglutaminase regulates beta-catenin signaling through a c-Src-dependent mechanism. FASEB J 2013;27:3100-12
   Google Scholar
• Mao Y, Xu J, Li Z, et al. The role of nuclear beta-catenin accumulation in the Twist2-induced ovarian cancer EMT. PLoS One 2013;8:e78200
   Google Scholar
• Lee JM, Dedhar S, Kalluri R, et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006;172:973-81
   PubMed Web of Science ®Google Scholar
• Vergara D, Merlot B, Lucot JP, et al. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 2010;291:59-66
   PubMed Web of Science ®Google Scholar
• Davidson B, Trope CG, Reich R. Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol 2012;2:33
   PubMedGoogle Scholar
• Vallin J, Thuret R, Giacomello E, et al. Cloning and characterization of three Xenopus slug promoters reveal direct regulation by Lef/beta-catenin signaling. J Biol Chem 2001;276:30350-8
   PubMed Web of Science ®Google Scholar
• Howe LR, Watanabe O, Leonard J, et al. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 2003;63:1906-13
   PubMed Web of Science ®Google Scholar
• Sanchez-Tillo E, Fanlo L, Siles L, et al. The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma. Cell Death Differ 2014;21:247-57
   Google Scholar
• ten Berge D, Koole W, Fuerer C, et al. Wnt signaling mediates self-organization and axis formation in embryoid bodies. Cell Stem Cell 2008;3:508-18
   PubMed Web of Science ®Google Scholar
• Lochter A, Galosy S, Muschler J, et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997;139:1861-72
   PubMed Web of Science ®Google Scholar
• Noe V, Fingleton B, Jacobs K, et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001;114:111-18
   PubMed Web of Science ®Google Scholar
• Liu Y, Burkhalter R, Symowicz J, et al. Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells. J Oncol 2012;2012:501492
   PubMedGoogle Scholar
• Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2010;2:a002915
   PubMed Web of Science ®Google Scholar
• Bachelder RE, Yoon SO, Franci C, et al. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 2005;168:29-33
   PubMed Web of Science ®Google Scholar
• Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004;6:931-40
   PubMed Web of Science ®Google Scholar
• Yook JI, Li XY, Ota I, et al. Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem 2005;280:11740-8
   PubMed Web of Science ®Google Scholar
• Wojcik C, Schroeter D, Wilk S, et al. Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome. Eur J Cell Biol 1996;71:311-18
   PubMed Web of Science ®Google Scholar
• Itoh K, Jenny A, Mlodzik M, et al. Centrosomal localization of Diversin and its relevance to Wnt signaling. J Cell Sci 2009;122:3791-8
   PubMed Web of Science ®Google Scholar
• Hanai J, Gloy J, Karumanchi SA, et al. Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol 2002;158:529-39
   PubMed Web of Science ®Google Scholar
• Lou B, Fan J, Wang K, et al. N1-guanyl-1,7-diaminoheptane (GC7) enhances the therapeutic efficacy of doxorubicin by inhibiting activation of eukaryotic translation initiation factor 5A2 (eIF5A2) and preventing the epithelial-mesenchymal transition in hepatocellular carcinoma cells. Exp Cell Res 2013;319:2708-17
   Google Scholar
• Liu Y, Du F, Chen W, et al. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin. Exp Cell Res 2013;319:3140-9
   Google Scholar
• Yang J, Yu H, Shen M, et al. N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation. Cancer Sci 2014;105:219-27
   PubMed Web of Science ®Google Scholar